相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort
Stefan Braune et al.
JOURNAL OF NEUROLOGY (2013)
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort
Tomas Olsson et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response
J. Rio et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
Afsaneh Shirani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique
Devon S. Conway et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Fingolimod for Multiple Sclerosis
Daniel Pelletier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial design
Richard Nicholas et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Long-term follow-up of clinical trials of multiple sclerosis therapies
Mark S. Freedman
NEUROLOGY (2011)
Anti-JC Virus Antibodies: Implications for PML Risk Stratification
Leonid Gorelik et al.
ANNALS OF NEUROLOGY (2010)
Detection of Viral DNA Sequences in the Cerebrospinal Fluid of Patients With Multiple Sclerosis
Roberta Mancuso et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
A method for evaluating treatment switching criteria in multiple sclerosis
Brian C. Healy et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
What can be learned from open direct comparative trials in multiple sclerosis?
Omar Khan
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA
E. Iacobaeus et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis
A. Gajofatto et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy
Hans Linda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Postmarketing evidence of disease-modifying drugs in multiple sclerosis
Maria Trojano et al.
NEUROLOGICAL SCIENCES (2008)
JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event
Roberto Alvarez-Lafuente et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
TA Yousry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Adjusted survival curves with inverse probability weights
SR Cole et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
分享论文
